Vimarsana
Biggest News Aggregation in the World

Page 32 - Mobile Android News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mobile Android. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mobile Android Today - Breaking & Trending Today

Older living kidney donor age may be negative predictor of recipient, graft survival - Vimarsana News

Older living kidney donor age may be negative predictor of recipient, graft survival

Compared with living donors aged 50 to 70 years, donor age older than 70 years may be a negative predictor of kidney transplant and graft survival, according to a presentation at the American Transplant Congress.“I set out to see if the data and outcomes of a national cohort met my anecdotal findings that living kidney donor transplants from donors [older than] 70 years don’t perform

Source: healio.com
Consider COVID-19 history when addressing sleep deprivation - Vimarsana News

Consider COVID-19 history when addressing sleep deprivation

CHARLOTTE, N.C. — A history of COVID-19 nearly doubled the odds of having very short sleep, according to results from a large U.S. study presented at SLEEP 2022. “Few studies have focused on factors associated with sleep quantity and quality,” Marie-Rachelle Narcisse, PhD, lead study author and assistant professor at the University of Arkansas for Medical Sciences Northwest,

Source: healio.com
Ifosfamide more likely to extend survival than topotecan-cyclophosphamide in Ewing sarcoma - Vimarsana News

Ifosfamide more likely to extend survival than topotecan-cyclophosphamide in Ewing sarcoma

CHICAGO — In what researchers described as the first randomized controlled trial of chemotherapy in relapsed or refractory Ewing sarcoma, high-dose ifosfamide proved more effective in extending survival than topotecan and cyclophosphamide. Martin G. McCabe, MD, PhD, clinical senior lecturer in pediatric and adolescent oncology at University of Manchester in the U.K., presented the

Source: healio.com
Targeted therapy provides 'phenomenal' benefit for certain children with glioma - Vimarsana News

Targeted therapy provides 'phenomenal' benefit for certain children with glioma

CHICAGO — A combination of two targeted therapies significantly improved outcomes compared with standard care for children with BRAF V600 mutation-positive low-grade glioma, according to study results presented at ASCO Annual Meeting.Dabrafenib (Tafinlar, Novartis) and trametinib (Mekinist, Novartis) increased response rate, extended PFS and improved clinical benefit rate compared with

Source: healio.com
Action needed to combat elevated risk for depression, suicide in diabetes - Vimarsana News

Action needed to combat elevated risk for depression, suicide in diabetes

NEW ORLEANS — Risks for depression and suicidal ideation are higher among people with vs. without diabetes, and cases of suicide are likely underreported, according to a presenter at the American Diabetes Association Scientific Sessions. Katharine Barnard-Kelly, PhD, chief science officer at Spotlight Consultations in Portsmouth, U.K., professor at the Southern Health NHS Foundation

Source: healio.com